7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
CAS: 2886-65-9
Ref. 3D-FC26451
1g | 177.00 € | ||
2g | 263.00 € | ||
5g | 489.00 € | ||
10g | 694.00 € | ||
500mg | 141.00 € |
Product Information
- 5-(2-Fluorophenyl)-1,3-dihydro-7-chloro-2H-1,4-benzodiazepin-2-oneNorfludiazepamDesalkylflurazepam
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-
- 2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(o-fluorophenyl)-1,3-dihydro-
- 5-(2-Fluorophenyl)-7-Chloro-1,4-Benzodiazepin-2-One
- 7-Chloro-1,3-dihydro-5-(2′-fluorophenyl)-2H-1,4-benzodiazapin-2-one
- 7-Chloro-5-(2-Fluoro-Phenyl)-1,3-Dihydro-2H-1,4-Benzodiazepin-2-One
- 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
- 7-Chloro-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one
- 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
- Cm 7116
- See more synonyms
- Dealkylflurazepam
- Desalkylflurazepam
- Descarbethoxyloflazepate
- N-1-Desalkylflurazepam
- N-Desalkyl-2-oxoquazepam
- N-Desalkylflutoprazepam
- Norflurazepam
- Norflutoprazepam
- Ro 5-3367
- Sch 17514
7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one is a GABA receptor antagonist that is used in the treatment of anxiety. It is an analogue of cinolazepam, which has been shown to inhibit the binding of gamma aminobutyric acid (GABA) to its receptors in human serum and urine samples. Cinolazepam was found to be more potent than 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4 benzodiazepin 2 one in blocking the binding of GABA to its receptor. This drug has also been tested on geriatric patients with high levels of anxiety and found to be well tolerated.
Chemical properties
Technical inquiry about: 3D-FC26451 7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.